Providence’s research in kidney health and diseases is on the cutting edge of identifying molecular signatures of diabetic kidney disease and development of new biomarkers and treatment targets. Our work is broadly translational from cellular and molecular biology to studies in mouse models to translational studies in humans and clinical trials of novel therapies. We also conduct research in a broad spectrum of other types of kidney diseases and treatments: glomerular diseases, hypertension and kidney vascular disease, nutritional approaches, patient-centered outcomes, and health services research. Importantly, Providence has funded a major initiative to establish a system-wide Chronic Kidney Disease registry that will greatly amplify both the quality-of-care we deliver and the research we conduct in our communities. We truly are at a tipping point. Astounding scientific breakthroughs will change the landscape toward kidney health and better life for people with kidney diseases.
Follow
Submissions from 2017
Link
Diabetes and CKD in the United States Population, 2009-2014., Leila R Zelnick, Noel S Weiss, Bryan R Kestenbaum, Cassianne Robinson-Cohen, Patrick J Heagerty, Katherine Tuttle, Yoshio N Hall, Irl B Hirsch, and Ian H de Boer
Submissions from 2014
Link
Stenting and medical therapy for atherosclerotic renal-artery stenosis., Christopher J Cooper, Timothy P Murphy, Donald E Cutlip, Kenneth Jamerson, William Henrich, Diane M Reid, David J Cohen, Alan H Matsumoto, Michael Steffes, Michael R Jaff, Martin R Prince, Eldrin F Lewis, Katherine Tuttle MD, Joseph I Shapiro, John H Rundback, Joseph M Massaro, Ralph B D'Agostino, and Lance D Dworkin
Reconciling the R.E.N.A.L. Nephrometry Tool and the updated NCCN Management Guidelines for Kidney Cancer. “Upholding Oncological Principles and Avoiding Chronic Kidney Disease.”, Mark J. Kelly
Submissions from 2009
Link
Should albuminuria be a focus of antihypertensive therapy goals?, Radica Alicic, Sandeep A Saha, Robert A Short, and Katherine Tuttle MD
A Resident Created Protocol for the Treatment of Diabetic Ketoacidosis in the ICU, Jason Hughes, DO
A Resident Created Protocol for the Treatment of Diabetic Ketoacidosis in the ICU, Jason Hughes, DO